Glenmark issues another recall, this time for nearly 1.5M bottles of generic ADHD drug
Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time it’s for just shy of 1.5 million bottles of the generic ADHD drug atomoxetine.
Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time it’s for just shy of 1.5 million bottles of the generic ADHD drug atomoxetine.
